BARCELONA, Spain & SEOUL, South Korea--(BUSINESS WIRE)--The Vall d’Hebron Research Institute (VHIR, www.vhir.org) in Barcelona, Spain, and the world-leading Genomics services company Macrogen (www.macrogen.com) (KRX 038290) in Seoul, South Korea, announced that they had signed a comprehensive Genomics service partnership agreement including Macrogen X-Genome (the Xpressway to Genome) services.
According to this agreement, Macrogen will provide various Genomics services including both the capillary sequencing service and the state-of-art next-generation sequencing (NGS) service to VHIR researchers. This agreement reinforces VHIR’ scientific and technical support services in an effort to strengthen its researcher’s capacity to discover and implement novel diagnosis and treatment measures. In this sense, VHIR’s researchers will benefit from the Macrogen-VHIR special program based on Macrogen’s comprehensive Genomics service portfolio. VHIR’s staff, composed of 1,200 researchers (mostly clinicians), is aimed to achieve a direct translation from research to applications, with the final goal of offering Vall d’Hebron Hospital patients the benefit of the most advanced knowledge. By means of this agreement, Macrogen will partner with VHIR to achieve its objective.
Help employers find you! Check out all the jobs and post your resume.
